Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration

Movement Disorders

Volumn 19, Issue 7, 2004, Pages 817-821

  Henkel, K ^a   Karitzky, J ^a   Schmid, M ^a   Mader, I ^b   Glatting, G ^a   Unger, J W ^a   Neumaier, B ^a   Ludolph, A C ^a   Reske, S N ^a   Landwehrmeyer, G B ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Corticobasal degeneration; Microglia; PK11195; Positron emission tomography

Indexed keywords

BENZODIAZEPINE RECEPTOR; CARBON 11; FLUORODEOXYGLUCOSE; LIGAND; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

AGED; ARTICLE; BASAL GANGLION; BINDING SITE; BRAIN METABOLISM; CASE REPORT; CLINICAL EXAMINATION; CORTICOBASAL DEGENERATION; HUMAN; IMAGE DISPLAY; IMAGING SYSTEM; IN VIVO STUDY; INCIDENCE; MALE; METABOLIC DISORDER; MICROGLIA; NERVE DEGENERATION; PARIETAL LOBE; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RIGHT HEMISPHERE; SYMPTOMATOLOGY; TEMPORAL CORTEX;

AGED; BASAL GANGLIA DISEASES; CEREBRAL CORTEX; FUNCTIONAL LATERALITY; HUMANS; ISOQUINOLINES; MAGNETIC RESONANCE IMAGING; MALE; MICROGLIA; NERVE DEGENERATION; RADIOPHARMACEUTICALS; RECEPTORS, GABA-A; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 4344683590     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20040     Document Type: Article

References (13)

1. Rebeiz JJ, Kolodny EH, Richardson EP. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968;18:20-33.
2. Gibb WRG, Luthert PJ, Marsden JD. Corticobasal degeneration. Brain 1989;112:1171-1192.
3. Armstrong RA, Cairns NJ, Lantos PL. A quantitative study of the pathological lesions in the neocortex and hippocampus of twelve patients with corticobasal degeneration. Exp Neurol 2000;163: 348-356.
4. Hauser RA, Murtaugh FR, Akhter K, Gold M, Olanow CW. Magnetic resonance imaging of corticobasal degeneration. J Neuroimaging 1996;6:222-226.
5. Laureys S, Salmon E, Garraux G, Peigneux P, Lemaire C, Degueldre C, Franck G. Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration. J Neurol 1999;246: 1151-1158.
6. Banati RB, Myers R, Kreutzberg GW. PK (peripheral benzodiazepine)-binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia. J Neurocytol 1997;26:77-82.
7. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-318.
8. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB. In-vivo measurement of activated microglia in dementia. Lancet 2001;358:461-467.
9. Cagnin A, Myers R, Gunn RN, Lawrence AD, Stevens T, Kreutzberg GW, Jones T, Banati RB. In vivo visualisation of activated glia by [11C] (R)-PK]1195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain 2001;124:2014-2027.
10. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 2000;123:2321-2337.
11. Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 2001;24:1121-1159.
12. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand- receptor imaging in PET using a simplified reference region model. Neuroimage 1997;6:279-287.
13. Gunn RN, Lammertsma AA, Cunningham VJ. Parametric imaging of ligand-receptor interactions using a reference tissue model and cluster analysis. In: Carson RE, Daube-Witherspoon ME, Herscovitch P, editors. Quantitative functional brain imaging with positron emission tomography. San Diego: Academic Press; 1998. p 401-406.